"XBB" の関連情報検索結果

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...



Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials  Nature.com

Genomic Surveillance for SARS-CoV-2 Variants: ... - CDC



Genomic Surveillance for SARS-CoV-2 Variants: ...  CDC

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine



Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design  Duke University School of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants - nejm.org



Durability of XBB.1.5 Vaccines against Omicron Subvariants  nejm.org

COVID-19 Variant Update - IDSA



COVID-19 Variant Update  IDSA

XBB booster offers protection against JN.1 infections, hospital cases, new data show - University...



XBB booster offers protection against JN.1 infections, hospital cases, new data show  University of Minnesota Twin Cities

Study Suggests Regular Vaccine Boosts May Help People Who Are Immunocompromised Fight COVID-19 - ...



Study Suggests Regular Vaccine Boosts May Help People Who Are Immunocompromised Fight COVID-19  Johns Hopkins Medicine

The Updated COVID Vaccines Are Here: 9 Things to Know > News - Yale Medicine



The Updated COVID Vaccines Are Here: 9 Things to Know > News  Yale Medicine

Updated BNT162b2 XBB COVID-19 Vaccine Protects Against Hospitalization in Children Aged 5 to 17 -...



Updated BNT162b2 XBB COVID-19 Vaccine Protects Against Hospitalization in Children Aged 5 to 17  Pharmacy Times

Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice - Frontiers



Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice  Frontiers

Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province...



Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 2023  Virology Journal

COVID-19 XBB-Adapted Vaccine Less Effective Against JN.1 vs XBB Sublineages - Infectious Disease ...



COVID-19 XBB-Adapted Vaccine Less Effective Against JN.1 vs XBB Sublineages  Infectious Disease Advisor

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature.com



Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System  Nature.com

Interim Effectiveness of Updated 2023–2024 ... - CDC



Interim Effectiveness of Updated 2023–2024 ...  CDC

Comparing the COVID-19 Vaccines: How Are They Different? > News - Yale Medicine



Comparing the COVID-19 Vaccines: How Are They Different? > News  Yale Medicine

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - Univ...



XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids  University of Minnesota Twin Cities

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...



Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines  Nature.com

Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths - University of Min...



Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths  University of Minnesota Twin Cities

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...



Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates  Nature.com

Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity - Nature.com



Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity  Nature.com

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...



Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation  Nature.com

Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booste...



Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booster  Nature.com

Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination...



Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination and infection  Wiley Online Library

Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do...



Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul  Nature.com

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...



Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion  Nature.com

Interim Effectiveness of Updated 2023–2024 ... - CDC



Interim Effectiveness of Updated 2023–2024 ...  CDC

Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XB...



Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants  Nature.com

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvar...



XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1  ScienceDirect.com

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature.com



Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant  Nature.com

Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England - The Lancet



Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England  The Lancet

Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Va...



Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024 - Antunes - 2024 - Influenza and Other Respiratory Viruses  Wiley Online Library

A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16,...



A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses  Nature.com

What to Know About COVID FLiRT Variants - Johns Hopkins Bloomberg School of Public Health



What to Know About COVID FLiRT Variants  Johns Hopkins Bloomberg School of Public Health

Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against bro...



Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping  Frontiers

New XBB.1.5 COVID-19 variant spreading rapidly through U.S. - UCLA Health



New XBB.1.5 COVID-19 variant spreading rapidly through U.S.  UCLA Health

XBB.1.16-RBD-based trimeric protein vaccine can effectively inhibit XBB.1.16-included XBB subvari...



XBB.1.16-RBD-based trimeric protein vaccine can effectively inhibit XBB.1.16-included XBB subvariant infection  Wiley Online Library

COVID is surging again. Here’s the latest on new variants, updated vaccines, and masking - AAMC



COVID is surging again. Here’s the latest on new variants, updated vaccines, and masking  AAMC

A Novel Circular Delta-XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elici...



A Novel Circular Delta-XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS-CoV-2 Variants in Mice  Wiley Online Library

Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...



Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study  The Lancet

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... - CDC



Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ...  CDC

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants | mBio ...



Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants | mBio  American Society for Microbiology

Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderl...



Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination  Nature.com

WHO COVID vaccine advisers recommend switch to JN.1 strain - University of Minnesota Twin Cities



WHO COVID vaccine advisers recommend switch to JN.1 strain  University of Minnesota Twin Cities

Will COVID Vaccines Continue to Work Against JN.1 and Other New Variants? - IDSA



Will COVID Vaccines Continue to Work Against JN.1 and Other New Variants?  IDSA

Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syr...



Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters  American Society for Microbiology

Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization - University of Min...



Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization  University of Minnesota Twin Cities

Symptoms and Preventions of the COVID Omicron-XBB Variant - Siloam Hospitals



Symptoms and Preventions of the COVID Omicron-XBB Variant  Siloam Hospitals

JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers an...



JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV  Wiley Online Library

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biol...



Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biology  Nature.com

Current COVID boosters offer good protection against severe outcomes but less so against JN.1 - U...



Current COVID boosters offer good protection against severe outcomes but less so against JN.1  University of Minnesota Twin Cities

New variants of COVID‐19 (XBB.1.5 and XBB.1.16, the “Arcturus”): A review of highly questioned co...



New variants of COVID‐19 (XBB.1.5 and XBB.1.16, the “Arcturus”): A review of highly questioned concerns, a brief comparison between different peaks in the COVID‐19 pandemic, with a focused systematic review on expert recommendations for prevention, v  Wiley Online Library

What you need to know about COVID FLiRT variants - Houston Public Media



What you need to know about COVID FLiRT variants  Houston Public Media

T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection - Nature.com



T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection  Nature.com

XBB.1.5 Updated COVID-19 Vaccine Less Effective Against SARS-CoV-2 Variants BA.2.86 & JN.1 - Phys...



XBB.1.5 Updated COVID-19 Vaccine Less Effective Against SARS-CoV-2 Variants BA.2.86 & JN.1  Physician's Weekly

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection - Scie...



Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection  ScienceDirect.com

Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story ci...



Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story circulating again  Africa Check

Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-...



Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance  BMC Infectious Diseases

3 Things to Know About XEC, the Dominant COVID Strain > News - Yale Medicine



3 Things to Know About XEC, the Dominant COVID Strain > News  Yale Medicine

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hA...



SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids  Frontiers

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...



What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infecti...



XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection  News-Medical.Net

Health expands vaccination campaign against the XBB variant of Covid-19 - Prefeitura da Cidade do...



Health expands vaccination campaign against the XBB variant of Covid-19  Prefeitura da Cidade do Rio de Janeiro

LB.1, or D-FLiRT, is the newest COVID subvariant. What do we know about it? Where has it come fro...



LB.1, or D-FLiRT, is the newest COVID subvariant. What do we know about it? Where has it come from?  The Conversation Indonesia

A health advisory about the COVID-19 xbb variant has not been issued by the CDC - WBIR.com



A health advisory about the COVID-19 xbb variant has not been issued by the CDC  WBIR.com

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization



TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization

Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1....



Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study  The Lancet

Individuals carrying the HLA-B*15 allele exhibit favorable responses to COVID-19 vaccines but are...



Individuals carrying the HLA-B*15 allele exhibit favorable responses to COVID-19 vaccines but are more susceptible to Omicron BA.5.2 and XBB.1.16 infection  Frontiers

XBB.1.5: What you need to know about COVID-19’s ‘Kraken’ variant - UC Davis Health



XBB.1.5: What you need to know about COVID-19’s ‘Kraken’ variant  UC Davis Health

Statement on the antigen composition of COVID-19 vaccines - World Health Organization



Statement on the antigen composition of COVID-19 vaccines  World Health Organization

Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters ...



Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters  Frontiers

CORONAVIRUS Public urged to get XBB vaccine amid surge in COVID-19 cases - Focus Taiwan



CORONAVIRUS Public urged to get XBB vaccine amid surge in COVID-19 cases  Focus Taiwan

Non-high-risk Hongkongers should get Covid XBB variant jab as first dose: experts - South China M...



Non-high-risk Hongkongers should get Covid XBB variant jab as first dose: experts  South China Morning Post

Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine



Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know  Yale Medicine

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster - nejm.org



Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster  nejm.org

Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic



Rising cases of COVID-19 variant, XBB.1.5  Mayo Clinic

What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS NewsHour



What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant  PBS NewsHour

How much should people worry about Covid’s newly-dominant XBB.1.5 variant? Our medical analyst ex...



How much should people worry about Covid’s newly-dominant XBB.1.5 variant? Our medical analyst explains  CNN

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...



Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants  Nature.com

Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent v...



Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals  The Lancet

What is known about new Covid variant XBB.1.5? - BBC.com



What is known about new Covid variant XBB.1.5?  BBC.com

An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5 - F...



An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5  Frontiers

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - nejm.org



Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  nejm.org

Statement on the antigen composition of COVID-19 vaccines - World Health Organization



Statement on the antigen composition of COVID-19 vaccines  World Health Organization

Early Estimates of Bivalent mRNA Booster Dose Vaccine ... - CDC



Early Estimates of Bivalent mRNA Booster Dose Vaccine ...  CDC

WHO issues initial Omicron XBB.1.16 risk assessment - University of Minnesota Twin Cities



WHO issues initial Omicron XBB.1.16 risk assessment  University of Minnesota Twin Cities

What to Know About EG.5 (Eris)—the Latest Coronavirus Strain > News - Yale Medicine



What to Know About EG.5 (Eris)—the Latest Coronavirus Strain > News  Yale Medicine

ECDC classifies XBB.1.5-like lineages with the amino acid change F456L as variants of interest fo...



ECDC classifies XBB.1.5-like lineages with the amino acid change F456L as variants of interest following an increase in SARS-CoV-2 transmission in EU/EEA countries and abroad  European Union

Updated COVID-19 Boosters and XBB.1.5: What You Need to Know - American Society for Microbiology



Updated COVID-19 Boosters and XBB.1.5: What You Need to Know  American Society for Microbiology

XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...



XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants | Scientific Reports  Nature.com

Coronavirus variant XBB.1.5 rises in the United States — is it a global threat? - Nature.com



Coronavirus variant XBB.1.5 rises in the United States — is it a global threat?  Nature.com

Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from prev...



Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China  Nature.com

MOH debunks claims that XBB Covid-19 variant more ‘toxic’ than Delta - The Straits Times



MOH debunks claims that XBB Covid-19 variant more ‘toxic’ than Delta  The Straits Times

Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 ...



Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023  Nature.com

The Importance of Booster Vaccine in Addressing Omicron XBB - Siloam Hospitals



The Importance of Booster Vaccine in Addressing Omicron XBB  Siloam Hospitals

Explainer: What do we know about COVID variant XBB.1.5? - Reuters.com



Explainer: What do we know about COVID variant XBB.1.5?  Reuters.com

Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious - Scientific American



Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious  Scientific American

Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany -...



Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany  The Lancet

Will New COVID Vaccines Work Against EG.5? - IDSA



Will New COVID Vaccines Work Against EG.5?  IDSA

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection - Natu...



Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection  Nature.com